Mah, India

Rajendra N Kankan

This inventor holds 2 USPTO granted patents. Top assignee: U & I Pharmaceuticals, Ltd.. Active years: 2002-2006.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Rajendra N Kankan. Retrieved from https://idiyas.com/inventor/rajendra-n-kankan

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 50.0

Average Co-Inventor Count = 3.0

ph-index = 2

Forward Citations = 58(Granted Patents)


Location History:

  • Mumbai, IN (2002)
  • Mah, IN (2006)

Company Filing History:


Years Active: 2002-2006

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovations in Pharmaceutical Compositions by Rajendra N Kankan

Introduction

Rajendra N Kankan is a notable inventor based in Maharashtra, India. He has made significant contributions to the field of pharmaceuticals, particularly in the development of new polymorphic forms of olanzapine. With a total of two patents to his name, Kankan's work focuses on improving treatments for various psychotic conditions.

Latest Patents

Kankan's latest patents include innovative pharmaceutical compositions that contain new polymorphic forms of olanzapine. These compositions are designed for the treatment of psychotic conditions, mild anxiety, and gastrointestinal issues. Specifically, they are effective in treating schizophrenia, acute mania, Bipolar I Disorder, psychotic mood disorder, and psychosis in patients with Alzheimer's disease. The invention also details the process for preparing three new polymorphic forms of olanzapine, which are beneficial for the same range of conditions.

Career Highlights

Rajendra N Kankan is associated with U & I Pharmaceuticals, Ltd., where he continues to advance his research and development efforts. His work has been instrumental in enhancing the efficacy of pharmaceutical treatments available for mental health disorders.

Collaborations

Kankan has collaborated with notable figures in the pharmaceutical industry, including Yusuf Khwaja Hamied and Dharmaraj R Rao. These collaborations have further enriched his research and contributed to the success of his innovations.

Conclusion

Rajendra N Kankan's contributions to pharmaceutical compositions demonstrate his commitment to improving mental health treatments. His innovative work in developing new polymorphic forms of olanzapine is paving the way for more effective therapies for patients suffering from various psychotic conditions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…